{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-056659","form_type":"8-K","ticker":"GRI","cik":"0001824293","company_name":"GRI Bio, Inc.","filed_at":"2025-12-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.636549+00:00","generated_at":"2026-05-16T13:23:05.408645+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"GRI Bio launches $6.7M public offering of common stock and warrants","bullets":["Offering comprises 2.6M shares, 8.1M pre-funded warrants ($0.0001/share), and 10.7M Series F warrants ($0.75/share) at $0.75 per unit.","Net proceeds expected ~$6.7M; funds working capital, product development, and general corporate purposes.","Closing anticipated December 12, 2025; H.C. Wainwright acts as placement agent with 7.0% cash fee plus warrants.","Company believes proceeds plus existing cash will fund operations into Q4 2026; 60-day lockup on further equity issuance."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-056659","json":"https://secwatch.observer/filing/0001628280-25-056659.json","markdown":"https://secwatch.observer/filing/0001628280-25-056659.md","text":"https://secwatch.observer/filing/0001628280-25-056659.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1824293/000162828025056659/0001628280-25-056659-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1824293/000162828025056659/val-20251211.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:23:05.408645+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}